PharmaNutra S.p.A.
Stock Details
Is it expensive?
Market Cap
545.72M
Trailing P/E Ratio
41.68
Forward P/E Ratio
29.93
PEG Ratio
0.95
870.41M
26.30
Price-to-Sales (TTM)
6.33
11.82
7.76
Is it profitable?
138.73M
Net Profit Margin (TTM)
15.15%
Gross Profit Margin
73.95%
Diluted EPS (TTM)
2.20
30.15%
Is it growing?
24.50%
41.90%
Is it risky?
0.10
25.64
19.10M
2.38
Who owns it?
16.56%
65.02%
0.00%
9.58M
3.28M
Does it pay?
5.32%
45.45%
May 4, 2026
--
How much cash?
29.00M
19.45M
14.56M
3.02
- Price (EOD)
- 90.80
- Percent Change
- +1.40 (1.57%)
- Previous Close
- 89.40
- Open
- --
- Low
- --
- High
- --
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€90.80
From 52W Low
--
From 52W High
--
Today
+1.57%
1Y Change
--
Today
€90.80
From 52W Low
--
From 52W High
--
Today
+1.57%
1Y Change
--
Today
€90.80
Fairly Priced
within its 1-year price range
€90.80
Rate of Change (ROC)
Insufficient price history
- Name
- PharmaNutra S.p.A.
- Founded
- 2000
- CEO
- Ahmed Khaled El-Hoshy
- Employees
- 128
- Fiscal Year End
- Dec 31, 2025
- Address
Via Campodavela 1
Pisa
PI
56122
Italy
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.pharmanutra.it
Indicators
Operating Cash Flow
19.45M
Net Income
21.02M
Backed by Cash
0.93
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
FTSE Italia Mid CapIndex FTSE Italia Mid Cap - ITMC |
Indicators
Operating Cash Flow
19.45M
Net Income
21.02M
Backed by Cash
0.93
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
545.72M
Trailing P/E Ratio
41.68
Forward P/E Ratio
29.93
PEG Ratio
0.95
870.41M
26.30
Price-to-Sales (TTM)
6.33
11.82
7.76
Is it profitable?
138.73M
Net Profit Margin (TTM)
15.15%
Gross Profit Margin
73.95%
Diluted EPS (TTM)
2.20
30.15%
Is it growing?
24.50%
41.90%
Is it risky?
0.10
25.64
19.10M
2.38
Who owns it?
16.56%
65.02%
0.00%
9.58M
3.28M
Does it pay?
5.32%
45.45%
May 4, 2026
--
How much cash?
29.00M
19.45M
14.56M
3.02
- Price (EOD)
- 90.80
- Percent Change
- +1.40 (1.57%)
- Previous Close
- 89.40
- Open
- --
- Low
- --
- High
- --
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€90.80
From 52W Low
--
From 52W High
--
Today
+1.57%
1Y Change
--
Today
€90.80
From 52W Low
--
From 52W High
--
Today
+1.57%
1Y Change
--
Today
€90.80
Fairly Priced
within its 1-year price range
€90.80
Rate of Change (ROC)
Insufficient price history
- Name
- PharmaNutra S.p.A.
- Founded
- 2000
- CEO
- Ahmed Khaled El-Hoshy
- Employees
- 128
- Fiscal Year End
- Dec 31, 2025
- Address
Via Campodavela 1
Pisa
PI
56122
Italy
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.pharmanutra.it
Related Heatmaps
FTSE Italia Mid CapIndex FTSE Italia Mid Cap - ITMC |